Panion & BF Biotech Inc.(TW:1760)
NT$47.70-1.65 (-3.34%)
TW:1760
Panion & BF Biotech Inc. financials statements
NT$47.70
At close:-1.65 (-3.34%)
Panion & BF Biotech Inc. (1760) Income Statement
Panion & BF Biotech Inc. Income Statement
Last quarter (Q2 2026), Panion & BF Biotech Inc.'s total revenue was NT$511.84M, an increase of 1.60% from the same quarter last year. In Q2, Panion & BF Biotech Inc.'s net income was NT$39.11M. See Panion & BF Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 2.06B | NT$ 2.03B | NT$ 1.88B | NT$ 2.40B | NT$ 1.90B | |
| NT$ 1.12B | NT$ 1.07B | NT$ 974.40M | NT$ 1.32B | NT$ 912.14M | |
| NT$ 809.00M | NT$ 855.10M | NT$ 817.57M | NT$ 904.55M | NT$ 744.71M | |
| Depreciation and Amortization | NT$ 138.42M | NT$ 164.42M | NT$ 170.39M | NT$ 163.55M | NT$ 143.62M |
| NT$ 446.27M | NT$ 405.32M | NT$ 327.22M | NT$ 504.62M | NT$ 343.05M | |
| NT$ 307.85M | NT$ 205.67M | NT$ 156.83M | NT$ 341.07M | NT$ 199.42M | |
| NT$ -13.81M | NT$ 11.77M | NT$ 11.88M | NT$ -80.56M | NT$ 17.31M | |
| NT$ 294.04M | NT$ 217.44M | NT$ 168.71M | NT$ 333.41M | NT$ 182.65M | |
| NT$ 190.17M | NT$ 124.52M | NT$ 77.22M | NT$ 182.34M | NT$ 104.40M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.22 | NT$ 1.45 | NT$ 0.90 | NT$ 2.13 | NT$ 1.32 |
| Diluted EPS | NT$ 2.22 | NT$ 1.45 | NT$ 0.90 | NT$ 2.12 | NT$ 1.32 |
| Weighted Average Shares Outstanding | 85.66M | 85.74M | 85.79M | 85.74M | 79.18M |
| Weighted Average Shares Outstanding (Diluted) | 85.66M | 85.80M | 85.79M | 85.83M | 79.24M |
Currency in TWD
